Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
NAAS Rating: 5.23 new
Vol. 6, Issue 11 (2017)

Resealed erythrocytes: A novel carrier

Supriya Pathak, Manoj Kumar Mishra, Md. Amman Maqbool, Adarsh Kesharwani and Anuradha Kesharwani
Carrier erythrocytes have been evaluated in thousands of drug administration in humans proving safety and efficacy of the treatments. Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents. Erythrocytes mediated drug delivery has been reported with therapeutic enzymes and antiviral agents to maximize therapeutic performance, reduce the side effects, as circulating depots for controlled drug release, drug targeting, treatment of parasitic diseases, hepatic tumors, removal of toxic agents etc. Resealed Erythrocytes are biocompatible, biodegradable, possess long circulation half-life and can be loaded with variety of active drug substances.
Pages: 330-333  |  588 Views  15 Downloads
How to cite this article:
Supriya Pathak, Manoj Kumar Mishra, Md. Amman Maqbool, Adarsh Kesharwani, Anuradha Kesharwani. Resealed erythrocytes: A novel carrier. Pharma Innovation 2017;6(11):330-333.
The Pharma Innovation Journal